Cargando…
Cisplatin-Based Chemotherapy of Human Cancers
Cisplatin (cis-diammine-dichloro-platinum II) was initially discovered to prevent the growth of Escherichia coli and was further recognized for its anti-neoplastic and cytotoxic effects on cancer cells. Administered intravenously to humans, cisplatin is used as first-line chemotherapy treatment for...
Autores principales: | Brown, Andrea, Kumar, Sanjay, Tchounwou, Paul B |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7059781/ https://www.ncbi.nlm.nih.gov/pubmed/32148661 |
Ejemplares similares
-
Molecular mechanisms of cisplatin cytotoxicity in acute promyelocytic leukemia cells
por: Kumar, Sanjay, et al.
Publicado: (2015) -
p53 as a unique target of action of cisplatin in acute leukaemia cells
por: Kumar, Sanjay, et al.
Publicado: (2022) -
Pharmacological Effects of Cisplatin Combination with Natural Products in Cancer Chemotherapy
por: Dasari, Shaloam, et al.
Publicado: (2022) -
Advances in Our Understanding of the Molecular Mechanisms of Action of Cisplatin in Cancer Therapy
por: Tchounwou, Paul B, et al.
Publicado: (2021) -
Trisenox disrupts MDM2-DAXX-HAUSP complex and activates p53, cell cycle regulation and apoptosis in acute leukemia cells
por: Kumar, Sanjay, et al.
Publicado: (2018)